Abstract:[18F]BAY-94-9172, [18F]AV-45, and [18F]GE-067 were FDA approved positron emission tomography (PET) imaging radiotracer of beta-amyloid plaques (A/3) in Alzheimer's disease (AD). However, the radiochemical syn-thesis requires multi-step reactions and complex procedure. Recently, a protocol for radiochemical synthesis of sulfur fluoride exchange (SuFEx) using ultrafast 19F/18F isotopic exchange had been reported. We developed three pairs of novel 18F-labeled radiotracers by the "SuFEx" method for PET imaging A/3 plaques. The 18F labeling reaction can be completed quickly (30 s) at room temperature and purified using solid-phase extraction (SPE). The radiochemical purity (RCP) of the products was all greater than 95 %. In vitro fluorescent staining using A/3-transgenesis mice section preliminary verified the affinity of tracers with A/3. Competitive binding assay dis -played high affinity of tracers for towards artificial A/31-42 aggregates (Ki values ranging from 3.53 +/- 0.39 to 42.0 +/- 4.24 nM). In vivo biodistribution and Micro-PET imaging showed that [18F] -Sulfur Fluoride beta-Amyloid ([18F] SFA 1-6) could penetration the blood-brain barrier (BBB) in wild-type mice, and [18F]SFA 5-6 had a high initial brain uptake value (3.65 +/- 0.9 % and 5.07 +/- 0.1 % ID/g, respectively) and a fast washout (Brain uptake2 min/60 min = 4.15 and 4.61, respectively) from the brain. In vitro autoradiography demonstrated the affinity of the [18F] SFA 5-6 to A/3 plaques in AD human brain tissues. Our results suggested that [18F]SFA maybe a potential PET radiotracers for detecting A/3 in Alzheimer's disease.

(R)- and (S)-18F-labeled 2-Arylbenzofurans with Improved Pharmacokinetics As Β-Amyloid Imaging Probes.

18F-Labeled 2-Phenylbenzoheterocycles with Chiral Dihydroxyl Side Chains As Β-Amyloid Imaging Probes.

Synthesis and Monkey-PET Study of (R)- and (S)-18F-labeled 2-Arylbenzoheterocyclic Derivatives As Amyloid Probes with Distinctive in Vivo Kinetics.

18F-Labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques

Synthesis and Biological Evaluation of 18F-Labled 2-Phenylindole Derivatives As PET Imaging Probes for Β-Amyloid Plaques

Preliminary Characterization and In Vivo Studies of Structurally Identical 18 F- and 125 I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques

Preliminary Characterization and in Vivo Studies of Structurally Identical 18F- and 125I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of Β-Amyloid Plaques

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques in Alzheimer’s Brains

18F-Labeled Benzyldiamine Derivatives As Novel Flexible Probes for Positron Emission Tomography of Cerebral Β-Amyloid Plaques.

Synthesis and Evaluation of Novel ¹⁸F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives As Ligands for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques.

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

18F-Radiolabeled Resveratrol Derivatives: Synthesis, Radiolabeling, and Preliminary Evaluation as β-Amyloid Plaque PET Agents

~(11)C labelled benzofuran derivatives as a new agent for β-amyloid imaging

Optically Pure Diphenoxy Derivatives As More Flexible Probes for Β-Amyloid Plaques

Radiolabeled pyridinyl analogues of dibenzylideneacetone as beta-amyloid imaging probes

2-Arylbenzothiazoles Labeled with [cpre/99mtc(co)3] and Evaluated As Β-Amyloid Imaging Probes.

Synthesis and Evaluation of Benzofuran-2-yl(phenyl)methanone Derivatives As Ligands for Β-Amyloid Plaques.

Novel Imaging Agents for Β-Amyloid Plaque Based on the N-benzoylindole Core.

Design, Synthesis, and Preliminary Evaluation of [18F]-Aryl Flurosulfates PET Radiotracers Via SuFEx Methods for Β-Amyloid Plaques in Alzheimer’s Disease

Fluorine-18-Labeled Diaryl-azines As Improved Β-Amyloid Imaging Tracers: from Bench to First-in-Human Studies